Tricuspid regurgitation echocardiography

Revision as of 18:46, 9 September 2014 by Rim Halaby (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

WikiDoc Resources for Tricuspid regurgitation echocardiography

Articles

Most recent articles on Tricuspid regurgitation echocardiography

Most cited articles on Tricuspid regurgitation echocardiography

Review articles on Tricuspid regurgitation echocardiography

Articles on Tricuspid regurgitation echocardiography in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tricuspid regurgitation echocardiography

Images of Tricuspid regurgitation echocardiography

Photos of Tricuspid regurgitation echocardiography

Podcasts & MP3s on Tricuspid regurgitation echocardiography

Videos on Tricuspid regurgitation echocardiography

Evidence Based Medicine

Cochrane Collaboration on Tricuspid regurgitation echocardiography

Bandolier on Tricuspid regurgitation echocardiography

TRIP on Tricuspid regurgitation echocardiography

Clinical Trials

Ongoing Trials on Tricuspid regurgitation echocardiography at Clinical Trials.gov

Trial results on Tricuspid regurgitation echocardiography

Clinical Trials on Tricuspid regurgitation echocardiography at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tricuspid regurgitation echocardiography

NICE Guidance on Tricuspid regurgitation echocardiography

NHS PRODIGY Guidance

FDA on Tricuspid regurgitation echocardiography

CDC on Tricuspid regurgitation echocardiography

Books

Books on Tricuspid regurgitation echocardiography

News

Tricuspid regurgitation echocardiography in the news

Be alerted to news on Tricuspid regurgitation echocardiography

News trends on Tricuspid regurgitation echocardiography

Commentary

Blogs on Tricuspid regurgitation echocardiography

Definitions

Definitions of Tricuspid regurgitation echocardiography

Patient Resources / Community

Patient resources on Tricuspid regurgitation echocardiography

Discussion groups on Tricuspid regurgitation echocardiography

Patient Handouts on Tricuspid regurgitation echocardiography

Directions to Hospitals Treating Tricuspid regurgitation echocardiography

Risk calculators and risk factors for Tricuspid regurgitation echocardiography

Healthcare Provider Resources

Symptoms of Tricuspid regurgitation echocardiography

Causes & Risk Factors for Tricuspid regurgitation echocardiography

Diagnostic studies for Tricuspid regurgitation echocardiography

Treatment of Tricuspid regurgitation echocardiography

Continuing Medical Education (CME)

CME Programs on Tricuspid regurgitation echocardiography

International

Tricuspid regurgitation echocardiography en Espanol

Tricuspid regurgitation echocardiography en Francais

Business

Tricuspid regurgitation echocardiography in the Marketplace

Patents on Tricuspid regurgitation echocardiography

Experimental / Informatics

List of terms related to Tricuspid regurgitation echocardiography

For the main page of tricuspid regurgitation, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transthoracic echocardiography (TTE) should be performed in a patient with suspected tricuspid regurgitation to confirm the diagnosis, determine the etiology, and to establish the baseline severity of disease.

Echocardiography

Transthoracic eschocardiogrpahy (TTE) is the diagnostic modality of choice to evaluate tricuspidregurgitation. TEE allows the evaluation of the following:[1]

  • Right ventricle structure and function
  • Right atrium structure and function
  • Inferior vena cava
  • The structure and function of the left chambers of the heart
  • The structures of the tricuspid valve and the underlying etiology of mitral regurgitation
  • Pulmonary artery pressure
  • Pressures in the heart chambers
  • The severity of the tricuspid regurgitation through the measurement of:
    • The trucuspid annular diameter in the apical 4-chamber view
    • Tricuspid valve leaflet tethering height
    • Tricuspid valve leaflet tethering area

When TTE is non diagnostic, transesophageal echocardiography (TEE) may be performed. However, TEE is not provide an optimal way to assess the tricuspid valve.[1]

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]

Class I
"1. TTE is indicated to evaluate severity of TR, determine etiology, measure sizes of right-sided chambers and inferior vena cava, assess RV systolic function, estimate pulmonary artery systolic pressure, and characterize any associated left-sided heart disease. (Level of Evidence: C)"
Class IIb
"1. CMR or real-time 3-dimensional echocardiography may be considered for assessment of RV systolic function and systolic and diastolic volumes in patients with severe TR (stages C and D) and suboptimal 2-dimensional echocardiograms. (Level of Evidence: C)"

2008 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Evaluation of Tricuspid Valve Disease in Adolescents and Young Adults(DO NOT EDIT)[2]

Class I
"1. Doppler echocardiography is indicated for the initial evaluation of adolescent and young adult patients with TR, and serially every 1 to 3 years, depending on severity. (Level C)"

Sources

  • 2008 ACC/AHA Guidelines incorporated into the 2006 guidelines for the management of patients with valvular heart disease [2]

References

  1. 1.0 1.1 1.2 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 129 (23): 2440–92. doi:10.1161/CIR.0000000000000029. PMID 24589852.
  2. 2.0 2.1 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter |month= ignored (help)

Template:WH

Template:WS